Role of hepatic STAT3 in the regulation of lipid metabolism

Kobe Journal of Medical Sciences

Volumn 54, Issue 4, 2008, Pages

  Kinoshita, Shinichi ^a   Ogawa, Wataru ^a   Okamoto, Yasuo ^a   Takashima, Mototsugu ^a   Inoue, Hiroshi ^a,b   Matsuki, Yasushi ^c   Watanabe, Eijiro ^c   Hiramatsu, Ryuji ^c   Kasuga, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Diabetes mellitus; Dyslipidemia; Gluconeogenesis; STAT3

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A OXIDASE; ADENOVIRUS VECTOR; FATTY ACID SYNTHASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STAT3 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE OVEREXPRESSION; GENE TRANSFER; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID METABOLISM; LIVER FUNCTION; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, LEPTIN; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR;

EID: 56049089150     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., and Darnell, J.E., Jr. 1999. Stat3 as an oncogene. Cell 98:295-303.
2. Eberle, D., Hegarty, B., Bossard, P., Ferre, P., and Foufelle, F. 2004. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86:839-848.
3. Gray, S., Wang, B., Orihuela, Y., Hong, E.G., Fisch, S., Haldar, S., Cline, G.W., Kim, J.K., Peroni, O.D., Kahn, B.B., and Jain, M.K. 2007. Regulation of gluconeogenesis by Kruppel-like factor 15. Cell Metab. 5:305-312.
4. Inoue, H., Ogawa, W., Ozaki, M., Haga, S., Matsumoto, M., Furukawa, K., Hashimoto, N., Kido, Y., Mori, T., Sakaue, H., Teshigawara, K., Jin, S., Iguchi, H., Hiramatsu, R., LeRoith, D., Takeda, K., Akira, S., and Kasuga, M. 2004. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 10:168-174.
5. Inoue, H., Ogawa, W., Asakawa, A., Okamoto, Y., Nishizawa, A., Matsumoto, M., Teshigawara, K., Matsuki, Y., Watanabe, E., Hiramatsu, R., Notohara, K., Katayose, K., Okamura, H., Kahn, C.R., Noda, T., Takeda, K., Akira, S., Inui, A., and Kasuga, M. 2006. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab. 3:267-275.
6. Lee, G.H., Proenca, R., Montez, J.M., Carroll, K.M., Darvishzadeh, J.G., Lee, J.I., and Friedman, J.M. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635.
7. Matsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, Y., Iguchi, H., Matsuki, Y., Hiramatsu, R., Shimano, H., Yamada, N., Ohno, S., Kasuga, M., and Noda, T. 2003. PKC?̈ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. J. Clin. Invest. 112:935-944.
8. Matsumoto, M., Pocai, A., Rossetti, L., Depinho, R.A., and Accili, D. 2007. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver. Cell Metab. 6:208-216.
9. Mayr, B., and Montminy, M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2:599-609.
10. Miyake, K., Ogawa, W., Matsumoto, M., Nakamura, T., Sakaue, H., and Kasuga, M. 2002. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J. Clin. Invest. 110:1483-1491.
11. O'Brien, R.M., Streeper, R.S., Ayala, J.E., Stadelmaier, B.T., and Hornbuckle, L.A. 2001. Insulin-regulated gene expression. Biochem. Soc. Trans. 29:552-558.
12. Okamoto, Y., Ogawa, W., Nishizawa, A., Inoue, H., Teshigawara, K., Kinoshita, S., Matsuki, Y., Watanabe, E., Hiramatsu, R., Sakaue, H., Noda, T., and Kasuga, M. 2007. Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK1. Diabetes 56:1000-1009.
13. Puigserver, P., Rhee, J., Donovan, J., Walkey, C.J., Yoon, J.C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., and Spiegelman, B.M. 2003. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction. Nature 423:550-555.
14. Radziuk, J., and Pye, S. 2001. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab. Res. Rev. 17:250-272.
15. Shaw, R.J., Lamia, K.A., Vasquez, D., Koo, S.H., Bardeesy, N., Depinho, R.A., Montminy, M., and Cantley, L.C. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642-1646.
16. Shimano, H. 2001. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog. Lipid Res. 40:439-452.
17. Stern, M.P., and Haffner, S.M. 1991. Dyslipidemia in type II diabetes. Implications for therapeutic intervention. Diabetes Care 14:1144-1159.
18. Sun, Y., Liu, S., Ferguson, S., Wang, L., Klepcyk, P., Yun, J.S., and Friedman, J.E. 2002. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J. Biol. Chem. 277:23301-23307.
19. Teshigawara, K., Ogawa, W., Mori, T., Matsuki, Y., Watanabe, E., Hiramatsu, R., Inoue, H., Miyake, K., Sakaue, H., and Kasuga, M. 2005. Role of Kruppel-like factor 15 in PEPCK gene expression in the liver. Biochem. Biophys. Res. Commun. 327:920-926.
20. Valera, A., Pujol, A., Pelegrin, M., and Bosch, F. 1994. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 91:9151-9154.
21. Van Raalte, D.H., Li, M., Pritchard, P.H., and Wasan, K.M. 2004. Peroxisome proliferator-activated receptor (PPAR)-α: a pharmacological target with a promising future. Pharm. Res. 21:1531-1538.
22. Witters, L.A. 2001. The blooming of the French lilac. J. Clin. Invest. 108:1105-1107.
23. Yoon, J.C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C.R., Granner, D.K., Newgard, C.B., and Spiegelman, B.M. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138.